Who founded Numerion Labs?

Numerion Labs was founded by Alex Levy, Izhar Wallach in 2012.

Who are Numerion Labs's investors?

Numerion Labs's investors include B Capital Group, B4 Capital, Colorcon Ventures, DCVC (Data Collective), Dolby Family Ventures, NEXT Canada, Y Combinator, AME Cloud Ventures and 11 more.

Where is Numerion Labs headquartered?

Numerion Labs is headquartered in San Francisco, US.

Numerion Labs

YC W15

San Francisco, US · Founded 2012 · 67 employees · 19 known investors

Find your way into Numerion Labs

Paths you didn't know you had: your email and LinkedIn already hold routes to the Numerion Labs team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Numerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.

Also known as Chematria Inc. · Atomwise

AI & Machine Learning Biotech Healthtech Medical Devices AI-powered Drug Discovery Deep Learning Drug discovery OncologyUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W15)

Numerion Labs was founded in 2012 by Alex Levy and Izhar Wallach.

Alex Levy Co-Founder, COO2013–2018Alex Levy co-founded Atomwise, an AI-focused drug discovery company with significant pharmaceutical partnerships, and previously led a computer vision research lab at the University of Toronto's Computer Science Department. He is currently CEO and co-founder of Atmo, which applies AI to weather forecasting.

Izhar Wallach Founder2012–2025Izhar Wallach founded Numerion Labs, which applies machine learning and computational chemistry to accelerate drug development.

Steve WorlandCEO

Pamela TsurudaVP, Biology

Mark Sabat VP, Medicinal ChemistryMark Sabat is VP of Medicinal Chemistry at Numerion Labs. He brings over 19 years of pharmaceutical discovery experience across multiple therapeutic areas, with a track record in drug development including clinical advancement of molecules and published expertise in structure-based and fragment-based drug design methodologies.

Kate StaffordVP, Machine Learning

Nicole DishotskyManager, People Operations

Jeffrey CerioGeneral Counsel

Board

Robert Mittendorf

Adam Seabrook Partner at B4 Capital

Mike Varney

Kemal Malik

Investors · 19

B Capital Grouplisted by B Capital GroupSan Francisco · $10M – $50M

How we know: a partner's Signal profile · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

B4 Capitallisted by B4 Capital$10M – $50M

Colorcon Ventureslisted by Colorcon Ventures$500K – $2.5M

How we know: Colorcon Ventures's portfolio page · Not right? Tell us

DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M

How we know: open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Dolby Family Ventureslisted by Dolby Family VenturesSan Francisco

How we know: Dolby Family Ventures's portfolio page · Y Combinator's founder network · open dataset · 5k.vc investor directory · Not right? Tell us

NEXT Canadalisted by NEXT CanadaToronto

How we know: NEXT Canada's portfolio page · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us